Guardant Health, Inc.
NASDAQGuardant Health has surged 22% in a week and 35% in a month — and the company's own executives are using the run-up to sell. The insider activity is the standout this week. On May 20, founder and CEO Amirali Talasaz sold across multiple tranches, offloading roughly 115,000 shares worth approximately $13.6 million at prices ranging from $105 to $112. The Chief Commercial Officer added…
Snapshot as of 22 Jun 2026
Guardant Health has surged 22% in a week and 35% in a month — and the company's own executives are using the run-up to sell. The insider activity is the standout this week. On May 20, founder and CEO Amirali Talasaz…
Guardant Health enters the back half of May with short sellers quietly backing away and analysts nudging targets higher — a combination that frames a more constructive backdrop heading into the June 17 Q1…
Guardant Health heads into its May 7 Q1 2026 earnings print with options positioning flashing the most bullish signal in months — a sharp contrast to how the stock was positioned just two weeks ago. The options market…
GH heads into its April 30 Q1 earnings release with short sellers retreating sharply — yet the stock keeps falling anyway. The clearest signal in the data is the divergence between short interest and price. Shorts…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GH — free to start on ORTEX.
Sign up for free →Open GH on ORTEX